Form 144 - Report of proposed sale of securities:
SEC Accession No. 0002044416-25-000003
Filing Date
2025-11-20
Accepted
2025-11-20 17:06:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3147
  Complete submission text file 0002044416-25-000003.txt   4634
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Subject) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36485 | Film No.: 251503844
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ARDELYX, INC. 400 FIFTH AVENUE, SUITE 210 WALTHAM MA 02451
Business Address
Reilly Joseph James (Reporting) CIK: 0002044416 (see all company filings)

Type: 144